Carnegie has published a new commissioned research report on
To access the full report and subscribe to future updates, visit https://www.carnegie.se/en/commissioned-research/eql-pharma/
© Modular Finance, source
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
50.2 SEK | +0.40% |
|
-3.09% | +50.30% |
12/06 | EQL Pharma Receives Approval for Listing to Nasdaq Stockholm Main Market | MT |
15/05 | Transcript : EQL Pharma AB, Q4 2024 Earnings Call, May 15, 2024 |
Carnegie has published a new commissioned research report on
To access the full report and subscribe to future updates, visit https://www.carnegie.se/en/commissioned-research/eql-pharma/
© Modular Finance, source
1st Jan change | Capi. | |
---|---|---|
+50.30% | 139M | |
-38.49% | 9.97B | |
-16.75% | 6.98B | |
-13.56% | 5.76B | |
-13.66% | 4.94B | |
-3.21% | 4.57B | |
+5.82% | 4.44B | |
+69.80% | 4.42B | |
-34.74% | 2.63B | |
-20.28% | 2.62B |